buy

Scholar Rock Holding buy Wedbush

Scholar Rock Holding

Start price

€13.50

/ 50%

Target price

07.05.25

Performance (%)

Price

Summary

This prediction is currently active. The prediction for Scholar Rock Holding disappoints with a performance of . This prediction currently runs until 07.05.25. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this prediction

Scholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.

Feedback

Performance without dividends (%)

Name	1w
Scholar Rock Holding
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Wedbush for this prediction

In the thread Scholar Rock Holding diskutieren

Prediction Buy

Perf. (%)

Target price 21.381

Change

Ends at

Scholar Rock Holding Co. (NASDAQ: SRRK) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $23.00 price target on the stock.

Ratings data for SRRK provided by MarketBeat

Wedbush